Medtronic, Inc. (NYSE:MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Aquamantys ® SBS 5.0 Sheathed Bipolar Sealer, a new addition to the ...
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today reported results of an retrospective study available online and in an upcoming print edition of the Journal of Spinal Disorders and ...
A generation of aging baby boomers means more knee replacement surgeries than ever, and a new device is helping orthopedic surgeons get the job done more safely. The Aquamantys system works by ...
Medtronic’s (NYSE:MDT) surgical technologies segment received a boost as the U.S. Food and Drug Administration approved the Aquamantys 3 System, a tool made possible by the company’s acquisition of ...
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges ...
The FDA granted 510(k) clearance to Medtronic’s Aquamantys SBS 5.0 Sheathed Bipolar Sealer for spine surgery, according to a news release. Medtronic acquired the technology last July when it purchased ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Aquamantys ® SBS 5.0 Sheathed ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today reported results of an retrospective study available online and in an upcoming print edition of the Journal of Spinal Disorders and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results